RESCUE OF SETD2 TUMOR SUPPRESSOR FUNCTIONS IS A NOVEL MECHANISM OF ACTION OF MIDOSTAURIN IN SYSTEMIC MASTOCYTOSIS (SM) AND MAY SERVE AS A BIOMARKER OF RESPONSE

被引:0
|
作者
Monaldi, C. [1 ]
Mancini, M. [2 ]
De Santis, S. [1 ]
Rondoni, M. [3 ]
Bruno, S. [1 ]
Papayannidis, C. [2 ]
Sartor, C. [1 ]
Cavo, M. [1 ,2 ]
Soverini, S. [1 ]
机构
[1] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Inst Hematol L&A Seragnoli, Bologna, Italy
[2] IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy
[3] Azienda USL Romagna, Emilia Romagna, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C10
引用
收藏
页码:23 / 23
页数:1
相关论文
共 2 条
  • [1] SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS
    Mancini, M.
    Monaldi, C.
    De Santis, S.
    Papayannidis, C.
    Rondoni, M.
    Sartor, C.
    Bruno, S.
    Curti, A.
    Zanotti, R.
    Bonifacio, M.
    Scaffidi, L.
    Pagano, L.
    Criscuolo, M.
    Ciceri, F.
    Elena, C.
    Tosi, P.
    Valent, P.
    Cavo, M.
    Soverini, S.
    HAEMATOLOGICA, 2022, 107 : 42 - 42
  • [2] Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
    Gao, Yang
    Kabotyanski, Elena B.
    Shepherd, Jonathan H.
    Villegas, Elizabeth
    Acosta, Deanna
    Hamor, Clark
    Sun, Tingting
    Montmeyor-Garcia, Celina
    He, Xiaping
    Dobrolecki, Lacey E.
    Westbrook, Thomas F.
    Lewis, Michael T.
    Hilsenbeck, Susan G.
    Zhang, Xiang H. -F.
    Perou, Charles M.
    Rosen, Jeffrey M.
    CANCER RESEARCH COMMUNICATIONS, 2021, 1 (03): : 178 - 193